KEAP1 and neoplasm: While a few isolated mutations to these locations have been reported and shown to mitigate NRF2-KEAP1 interactions32, we focused on the R34 mutation and found it to be the most frequently mutated amino acid position and the only position significantly enriched across many tumor types.